Kimelman & Baird’s CME Group CME Stock Holding History

Kimelman & Baird’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$95.4K	Hold	323	–	–	0.01%	145
2025 Q4	$88.2K	Hold	323	–	–	0.01%	147
2025 Q3	$87.3K	Hold	323	–	–	0.01%	151
2025 Q2	$89K	Hold	323	–	–	0.01%	154
2025 Q1	$85.7K	Buy	323 +285	+750%	+$70.3K	0.01%	156
2024 Q4	$8.82K	Hold	38	–	–	﹤0.01%	269
2024 Q3	$8.38K	Hold	38	–	–	﹤0.01%	279
2024 Q2	$7.47K	Buy	+38	New	+$7.85K	﹤0.01%	284

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kimelman & Baird's CME Position: Q1 2026 in Review

Kimelman & Baird held its CME Group (CME) position steady in Q1 2026 at 323 shares worth $95.4K. The position accounts for 0.01% of the portfolio, ranked #145.

Kimelman & Baird first reported a position in CME in Q2 2024 and has held it in 8 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Kimelman & Baird held 323 shares of CME Group worth $95.4K as of Q1 2026.
Kimelman & Baird left its CME Group share count unchanged in Q1 2026.
CME Group made up 0.01% of Kimelman & Baird's portfolio in Q1 2026, its #145 holding.
Kimelman & Baird first reported a position in CME Group in Q2 2024 and has held it in 8 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.